On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products.

Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

●    Exceptional business momentum in the first half, with revenue up 16.1% at constant exchange rates

●    Strong growth in adjusted current operating income1 
      ○ +3.4 points compared with 2023 to reach a record level at 21.4% of revenue

●    2024 targets confirmed  
      ○    Revenue growth expected between 7% and 9% at constant exchange rates and scope
      ○    Adjusted current operating income1 expected to be around 16% compared with 15.1% in 2023